Literature DB >> 2998768

Structural prerequisites of simian virus 40 large T antigen for the maintenance of cell transformation.

M Montenarh, M Kohler, G Aggeler, R Henning.   

Abstract

We have investigated the functional roles of two structural subsets of simian virus 40 (SV40) large T antigen, namely homo-oligomers and complexes with the host cellular p53 protein, for the transformed phenotype. We examined T antigen produced in cells transformed by temperature-sensitive SV40 large T mutants: heat-sensitive or unrestricted SV40 tsA58-transformed rat cells and unrestricted tsA1499 transformants. In both unrestricted cell lines, T antigen was temperature-sensitive only for the formation of fast sedimenting homo-oligomers. Corresponding to our recent observations obtained with tsA1499-infected monkey cells, in tsA1499 transformants large T was competent to form stable T-p53 complexes independently of the temperature. However, T antigen coded for by tsA58, which is heat-sensitive for binding to p53, occurred in stable complexes with this protein in unrestricted tsA58 transformants under all conditions. Furthermore, in both unrestricted transformants T-p53 complexes arise in the absence of homo-oligomers of T antigen. In conclusion, T antigen homo-oligomers are not involved in cell transformation, whereas T-p53 complexes may be involved in the maintenance of this phenotype.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998768      PMCID: PMC554602          DOI: 10.1002/j.1460-2075.1985.tb04027.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  The simian virus 40 sequences between 0.169 and 0.423 map units are not essential to immortalize early-passage rat embryo cells.

Authors:  L Sompayrac; K J Danna
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

2.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

3.  SV40 early mutants that are defective for viral DNA synthesis but competent for transformation of cultured rat and simian cells.

Authors:  Y Gluzman; B Ahrens
Journal:  Virology       Date:  1982-11       Impact factor: 3.616

4.  Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.

Authors:  W E Mercer; D Nelson; A B DeLeo; L J Old; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

5.  Mutant of simian virus 40 large T-antigen that is defective for viral DNA synthesis, but competent for transformation of cultured rat cells.

Authors:  J R Stringer
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

6.  Relationship of oligomerization to enzymatic and DNA-binding properties of the SV40 large T antigen.

Authors:  M K Bradley; J D Griffin; D M Livingston
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

7.  Structure and biochemical functions of four simian virus 40 truncated large-T antigens.

Authors:  F Chaudry; R Harvey; A E Smith
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

8.  Time-dependent maturation of the simian virus 40 large T antigen-p53 complex studied by using monoclonal antibodies.

Authors:  R B Carroll; E G Gurney
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

9.  Comparison of T antigen-associated host phosphoproteins from SV40-infected and -transformed cells of different species.

Authors:  E Fanning; C Burger; E G Gurney
Journal:  J Gen Virol       Date:  1981-08       Impact factor: 3.891

10.  Complex of simian virus 40 large tumor antigen and 48,000-dalton host tumor antigen.

Authors:  D S Greenspan; R B Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  12 in total

1.  Thermally inactivated simian virus 40 tsA58 mutant T antigen cannot initiate viral DNA replication in vitro.

Authors:  I Reynisdóttir; D R O'Reilly; L K Miller; C Prives
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Oligomerization of oncoprotein p53.

Authors:  S Kraiss; A Quaiser; M Oren; M Montenarh
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  Replication and transformation functions of in vitro-generated simian virus 40 large T antigen mutants.

Authors:  J E Rutila; M J Imperiale; W W Brockman
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Overproduction of protein p53 contributes to simian virus 40-mediated transformation.

Authors:  D Michalovitz; D Eliyahu; M Oren
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

5.  Complex formation of simian virus 40 large T antigen with cellular protein p53.

Authors:  M Montenarh; M Kohler; R Henning
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Dimers and complexes with p53 are the prevalent oligomeric forms of a transforming nonkaryophilic T antigen of simian virus 40.

Authors:  M Montenarh; C Vesco; K H Scheidtmann
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

7.  Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines.

Authors:  P W Hinds; C A Finlay; A B Frey; A J Levine
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

8.  Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex.

Authors:  T H Tan; J Wallis; A J Levine
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

9.  Primary rat cells expressing a hybrid polyomavirus-simian virus 40 large T antigen have altered growth properties.

Authors:  J J Manfredi; C Prives
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Two conditional tsA mutant simian virus 40 T antigens display marked differences in thermal inactivation.

Authors:  I Reynisdóttir; C Prives
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.